First Trust Advisors
ARNA

First Trust Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

First Trust Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29,276
Closed -$2.25M – 2488
2020
Q4 		$2.25M Buy
29,276
+14,238
+95% +$1.07M ﹤0.01% 1514
2020
Q3 		$1.13M Sell
15,038
-28,257
-65% -$1.88M ﹤0.01% 1699
2020
Q2 		$2.73M Buy
43,295
+6,419
+17% +$353K ﹤0.01% 1225
2020
Q1 		$1.55M Buy
36,876
+509
+1% +$23.3K ﹤0.01% 1395
2019
Q4 		$1.65M Sell
36,367
-27,634
-43% -$1.31M ﹤0.01% 1654
2019
Q3 		$2.93M Buy
+64,001
New +$3.6M 0.01% 1312
2019
Q2 		– Sell
-18,157
Closed -$814K – 2540
2019
Q1 		$814K Sell
18,157
-2,550
-12% -$117K ﹤0.01% 1945
2018
Q4 		$807K Sell
20,707
-29,549
-59% -$1.16M ﹤0.01% 1937
2018
Q3 		$2.31M Sell
50,256
-8,187
-14% -$332K ﹤0.01% 1586
2018
Q2 		$2.55M Buy
+58,443
New +$2.51M 0.01% 1506

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Trust Advisors's ARNA Position: Q1 2021 in Review

First Trust Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 29,276 shares — an estimated $2.25M sold.

First Trust Advisors first reported a position in ARNA in Q2 2018 and held it in 10 quarters. The position peaked at $2.93M in Q3 2019. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • First Trust Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • First Trust Advisors sold 29,276 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $2.25M.
  • First Trust Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and held it in 10 quarters.
  • First Trust Advisors's Arena Pharmaceuticals Inc position peaked at $2.93M in Q3 2019.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on First Trust Advisors's 13F filing for Q1 2021, filed 14 May 2021.